secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001683168-23-003863
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio raises ~$4M in concurrent registered direct offering and private placement at $4.28/share
--------------------------------------------------------------------------------

- Gross proceeds ~$4M; net proceeds ~$3.5M after fees; closed June 2, 2023.
- Issued 233,646 shares in registered direct and 700,935 shares (or pre-funded warrants) in private placement at $4.28 each.
- Issued Series A (5.5-yr term) and Series B (18-mo term) warrants to purchase up to 934,581 shares each at $4.03.
- Proceeds to fund immuno-oncology programs, working capital, and general corporate purposes.
- H.C. Wainwright acted as placement agent; received 7.5% cash fee and warrants to purchase 70,094 shares at $5.35.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316823003863/0001683168-23-003863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316823003863/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-003863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer